Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6TPK

Crystal structure of the human oxytocin receptor

Summary for 6TPK
Entry DOI10.2210/pdb6tpk/pdb
DescriptorOxytocin receptor, (3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione, CHOLESTEROL, ... (4 entities in total)
Functional Keywordseukaryotic, protein, hormone receptor
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight57149.90
Authors
Waltenspuehl, Y.,Schoeppe, J.,Ehrenmann, J.,Kummer, L.,Plueckthun, A. (deposition date: 2019-12-13, release date: 2020-08-05, Last modification date: 2025-04-09)
Primary citationWaltenspuhl, Y.,Schoppe, J.,Ehrenmann, J.,Kummer, L.,Pluckthun, A.
Crystal structure of the human oxytocin receptor.
Sci Adv, 6:eabb5419-eabb5419, 2020
Cited by
PubMed Abstract: The peptide hormone oxytocin modulates socioemotional behavior and sexual reproduction via the centrally expressed oxytocin receptor (OTR) across several species. Here, we report the crystal structure of human OTR in complex with retosiban, a nonpeptidic antagonist developed as an oral drug for the prevention of preterm labor. Our structure reveals insights into the detailed interactions between the G protein-coupled receptor (GPCR) and an OTR-selective antagonist. The observation of an extrahelical cholesterol molecule, binding in an unexpected location between helices IV and V, provides a structural rationale for its allosteric effect and critical influence on OTR function. Furthermore, our structure in combination with experimental data allows the identification of a conserved neurohypophyseal receptor-specific coordination site for Mg that acts as potent, positive allosteric modulator for agonist binding. Together, these results further our molecular understanding of the oxytocin/vasopressin receptor family and will facilitate structure-guided development of new therapeutics.
PubMed: 32832646
DOI: 10.1126/sciadv.abb5419
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.2 Å)
Structure validation

235183

PDB entries from 2025-04-23

PDB statisticsPDBj update infoContact PDBjnumon